Beschreibung:
<jats:p><jats:bold>Abstract: </jats:bold> Plasma exchange has been proposed as support therapy in both acute and chronic forms of multiple sclerosis (MS). For the first time, we aimed to assess whether double filtration plasmapheresis (DFPP) could be clinically efficacious. We describe the case of a patient affected by MS who developed a severe crisis refractory to conventional steroids, and immunosuppressive and immunomodulating therapy. The patient underwent 12 sessions of DFPP. In each session 3000 mL of plasma was treated. Before and immediately after each session the routine laboratory parameters were assessed. Before the apheresis cycle and one month after the end of treatment, encephalic magnetic resonance imaging (MRI) was performed. A neurological examination and assessment of the extended disability status scale (EDSS) were made once each week from the beginning of treatment until one month after the end of the cycle. No therapy was administered during the course of the apheresis cycle, with the exception of a scaled dose of steroids, that was completely withdrawn half‐way through the cycle. The immunoglobulin (Ig) G, IgA and IgM values declined from 465 ± 104 mg/dL, 69 ± 18 mg/dL, 34 ± 16 mg/dL, respectively, pre‐apheresis to 331 ± 76 mg/dL, 42 ± 5 mg/dL, 15 ± 6 mg/dL, respectively, post‐apheresis; C3 and C4 decreased from 105 ± 27 mg/dL and 21 ± 5 mg/dL to 75 ± 9 mg/dL and 15 ± 4 mg/dL, respectively; fibrinogen went from 228 ± 72 mg/dL to 128 ± 28 mg/dL. The EDSS dropped from a value of 6 before the cycle to 5.5 one month after the end of the treatment. As compared with the pretreatment conditions, post‐apheresis MRI showed stabilization of the lesions already present, the reduction of one lesion and a complete absence of enhancement of all lesions. DFPP, adopted for the first time in MS, seems to foster a short‐term improvement in both the clinical and magnetic resonance images during an acute MS episode.</jats:p>